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T cells are critical for the control of viral infections and T cell responses are regulated by a
dynamic network of non-coding RNAs, including microRNAs (miR) and long non-coding
RNAs (lncRNA). Here we show that an activation-induced decline of lncRNA growth
arrest-specific transcript 5 (GAS5) activates DNA damage response (DDR), and regulates
cellular functions and apoptosis in CD4 T cells derived from people living with HIV (PLHIV)
via upregulation of miR-21. Notably, GAS5-miR21-mediated DDR and T cell dysfunction
are observed in PLHIV on antiretroviral therapy (ART), who often exhibit immune activation
due to low-grade inflammation despite robust virologic control. We found that GAS5
negatively regulates miR-21 expression, which in turn controls critical signaling pathways
involved in DNA damage and cellular response. The sustained stimulation of T cells
decreased GAS5, increased miR-21 and, as a result, caused dysfunction and apoptosis
in CD4 T cells. Importantly, this inflammation-driven T cell over-activation and aberrant
apoptosis in ART-controlled PLHIV and healthy subjects (HS) could be reversed by
antagonizing the GAS5-miR-21 axis. Also, mutation of the miR-21 binding site on
exon 4 of GAS5 gene to generate a GAS5 mutant abolished its ability to regulate
miR-21 expression as well as T cell activation and apoptosis markers compared to
the wild-type GAS5 transcript. Our data suggest that GAS5 regulates TCR-mediated
activation and apoptosis in CD4 T cells during HIV infection through miR-21-mediated
signaling. However, GAS5 effects on T cell exhaustion during HIV infection may be
mediated by a mechanism beyond the GAS5-miR-21-mediated signaling. These results
indicate that targeting the GAS5-miR-21 axis may improve activity and longevity of
CD4 T cells in ART-treated PLHIV. This approach may also be useful for targeting other
infectious or inflammatory diseases associated with T cell over-activation, exhaustion,
and premature immune aging.
Keywords: Gas5, HIV, lncRNA, miR-21, T cell dysregulation
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INTRODUCTION

CD4 T cells derived from ART-controlled PLHIV and agematched healthy subjects (HS). Notably, GAS5 controlled
miR-21 expression and regulated signaling molecules involved
in DNA damage and cellular responses following T cell
receptor (TCR) stimulation. Importantly, interrupting this
GAS5-miR-21 axis during TCR activation reversed T cell
dysfunction and rescued apoptosis in CD4 T cells derived
from ART-treated PLHIV. Our data suggest that GAS5
regulates TCR-induced activation and apoptosis of CD4 T cells
during HIV infection through a miR-21-mediated signaling.
However, T cell exhaustion during HIV infection may be
mediated by a mechanism beyond the GAS5-miR-21-mediated
signaling. This study provides a novel strategy to improve
immunotherapies and vaccine responses in the setting of latent
HIV infection.

HIV/AIDS pandemic affects 1.1 million individuals in the
United States and more than 36 million people worldwide
(1, 2). The hallmark of HIV/AIDS is a gradual depletion
of CD4 T cells, with progressive decline of host immunity,
leading to an increased susceptibility to opportunistic infections,
malignancies, and ultimately death (3, 4). While combined
antiretroviral therapy (ART) can effectively control viral
replication in the majority of people living with HIV (PLHIV),
ART does not always result in complete recovery of CD4 T
cells (5, 6). Even with satisfactory salvage of CD4 T cell
numbers, ART-controlled PLHIV often exhibit immunologic
scarring and residual inflammation, inducing an inflammaging
phenotype that is characterized by shortened telomeres, poor
proliferative capacity, and blunted vaccine responses (7–
10). The inflammaging imposed by latent HIV infection
exposes the immune system to unique challenges that lead to
profound T cell exhaustion and senescence, a major driver
of increased infections, cancers, cardiovascular diseases, and
neurodegeneration, and similar to what is observed in the elderly
(11, 12). Therefore, it is fundamentally important to elucidate
the mechanisms underlying T cell aging in PLHIV with ARTcontrolled latent infection.
In addition to protein-coding genes, the human genome
expresses different classes of non-coding RNAs, including
microRNAs (miRNA) and long non-coding RNAs (lncRNA) (13–
16). Overall, protein-coding genes account for only 2% of the
human genome, whereas the vast majority of gene transcripts
are non-coding RNAs. MiRNAs (∼20 nucleotides) and lncRNAs
(>200 nucleotides) are RNA transcripts that do not encode
proteins but possess regulatory functions. Using RNA sequencing
and annotation of the GENECODE project (17), recent studies
revealed over 30,000 lncRNAs (listed at www.noncode.org and
www.lncipedia.org), and this number continues to grow, but the
functions of these lncRNAs remain largely elusive.
The growth arrest-specific transcript 5 (GAS5) is a lncRNA
originally isolated from murine NIH 3T3 cells, and later
identified in human cells (NR_002578 and AF141346) (18). GAS5
is induced under stress conditions such as serum starvation and
cell-cell contact inhibition and has been reported to possess
tumor-suppressive functions in humans (19–24). GAS5 has also
been shown to inhibit tumor growth by regulating miR-21
(19, 24), a miRNA that regulates inflammation and immune
response (25–28). Of note, the expressions and functions of
lncRNAs, as well as miRNAs, are species-, cell-, and diseasespecific. In addition to suppressing cancer development and
metastasis in humans, GAS5 has been shown to control HIV
replication through interaction with miR-873 (29), but its role
in regulating T cell functions in ART-controlled HIV infection
remains unclear.
We have previously shown that PLHIV exhibit CD4 T cell
exhaustion, senescence, apoptosis, and dysfunction, despite
ostensibly complete control of viral replication by ART (30–36).
How T cell functions are dysregulated in ART-controlled
PLHIV is incompletely understood. In this study, we observed
differential regulation of GAS5 and miR-21 expressions in
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MATERIALS AND METHODS
Subjects
The study protocol was approved by the institutional review
board (IRB) of East Tennessee State University and James
H. Quillen VA Medical Center (ETSU/VA IRB; Johnson City,
Tennessee). All participants were adults and signed informed
consent forms. Participants included 142 people living with HIV
(PLHIV) and 58 age-matched HS. All PLHIV participants were
on ART, virologically suppressed as evidenced by undetectable
(<20 copies/ml) viral RNAs. Blood from HS was supplied by
Physicians Plasma Alliance (PPA, Gray, TN) and was negative for
HBV, HCV, and HIV infections. The demographic information of
all participants is listed in Table 1.

Cell Isolation and Culture
PBMCs were isolated from whole blood of HS and PLHIV
using Ficoll-Paque solution (GE Healthcare; Piscataway, NJ)
and density gradient centrifugation separation. CD4 T cells
were purified from PBMCs using CD4 T cell negative selection
kit (Miltenyi Biotec; Auburn, CA). The cells were cultured
for 24 h in RPMI-1640 media (Fisher Scientific; Pittsburgh,
PA) supplemented with 10% heat-inactivated fetal bovine
serum (Atlanta Biologicals; Flowery Branch, GA), 100 IU/ml
penicillin, and 2 mM L-glutamine (Thermo Scientific; Logan,
Utah) at 37◦ C and 5% CO2 atmosphere. For TCR stimulation,
CD4 T cells were cultured in media containing Dynabeads
coated with human T-activator CD3/CD28 (Fisher Scientific).

TABLE 1 | Demographic information of the study participants.
Total

Gender
male/female

Age mean
(SD/range)

CD4 count
mean
(SD/range)

HS

58

46/12

43 (9/34)

N/A

PLHIV

142

122/20

48 (9/47)

987
(389/2,245)

This table consists of demographic information of the participants in this study, including
the total number of subjects, gender (M/F), age (SD/Range), and CD4 number (SD/Range)
of each group, either HS or PLHIV.
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Precipitation Solution (System Bioscience) according to the
manufacturer’s instructions.
Isolated CD4 T cells from HS or PLHIV were stimulated with
soluble anti-CD3 and anti-CD28 for 2 days before lentiviral
infection. The transdux max (System Bioscience) reagent was
used followed the manufacturer protocol to enhance the infection
efficiency. CD4 T cells were harvested 3 days post infection and
subjected for further experiments.

For knockdown and overexpression experiments, the cells
were stimulated with soluble CD3/CD28 (BD biosciences; San
Jose, CA) and recombinant human IL-2 (PeproTech; Rocky
Hill, NJ) for 2 days prior to lentivirus infections and for
another 3 days post transfection. For anti-PD-1 treatment
and IL-2 administration experiment, CD4 T cells isolated from
HS were cultured for 24 h in the presence of Dynabeads
coated with human T cell activator anti-CD3/CD28, antiPD-1 (nivolumab, 20 µg/ml; Selleckchem, TX), human IgG4
isotype control antibody antibodies (Biolegend), or IL-2 (100
units/ml; Biolegend).

RNA Extraction, cDNA Synthesis, and
Real-Time RT-PCR
Total RNA was extracted from ∼1 × 106 CD4 T cells
isolated from each subject using the RNeasy Mini Kit (Qiagen;
Germantown, MD). Approximately 100 ng of RNA was
reverse transcribed using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems; Foster City, CA).
For miRNA measurements, miRNA was extracted using the
miRNeasy Micro kit (Qiagen) and cDNA was synthesized using
the TaqMan Advanced miRNA cDNA Synthesis Kit (Qiagen)
following the manufacturer’s instructions.
Quantitative real-time PCR was performed using iTag
Universal SYBR Green Supermix (Bio-Rad; Hercules, CA).
Gene expression was determined using the 2−11ct method and
normalized to GAPDH (for mRNA and lncRNA expressions)
and miR-191-5p (for miRNA expression), and the results are
presented as relative fold changes. The PCR primers are listed
in Table 2.

Lentiviral-Mediated shRNA Knockdown or
Overexpression
The following constructs were used in this study: GreenPuro
Scramble Hairpin Control (System Biosciences; Palo Alto,
CA), miRZip-21 anti-miR-21 (System Biosciences), and control
vector and GAS5 constructs as described previously (24).
Gas5-mutant construct was generated using Q5 Site-Directed
Mutagenesis Kit (New England BioLab, E0554S) according
to manufacturer’s protocol. Briefly, GAS5 WT vector was
used as the template for site-directed mutagenesis PCR with
primers (sequences shown in Table 1) that target exon 4
of GAS5 WT transcript, abolishing the miR-21 binding site
on GAS5. The primers were generated using NEBaseChanger
site (New England Biolab). DNA plasmid was transfected
into Stbl3TM chemically competent E. Coli (Introvigen). The
transformed cells were cultured on agar plates, positive
colonies were selected for plasmid DNA isolation. The plasmid
DNA was then subjected for DNA sequencing to confirm
the mutation.
The control, GAS5-WT, and GAS5-mutant vectors were
transfected into HEK 293T cells (ATCC) together with
psPAX2 and PMD2G vectors to generate the respective
lentiviruses using the FuGENE R HD Transduction Reagent
(System Bioscience). HEK 293T cells were cultured in DMEM
media (Fisher Scientific) containing 10% fetal bovine serum,
100 IU/ml penicillin, and 2 mM L-glutamine at 37◦ C and
5% CO2 atmosphere. The supernatants were collected and
the virus particles were concentrated using PEG-it Virus

Flow Cytometry
Sample preparation and surface and intracellular marker staining
were performed using the following antibodies, according to
the manufacturer’s protocols: anti-human CD279 (PD-1)/PE
[NAT105] (35), H2A.X Phospho (Ser139)/PE [2F3], CD69/FITC
[FN50], IL-2/PE [MQ1-17H12], IFN-γ /PE [4S.B3], TNF-α /APC
[MAb11], CD366 (Tim-3)/APC [F38-2E2], Phospho-AKT/ APC
(Ser473) [SDRNR], MAPK/Alexa Fluor 488 [pT180/pY182],
Bcl-2/Alexa Fluor 647 [C-2], and TGF-β1/PE [TW4-2F8] (all
from Biolegend; San Diego, CA). The cells were stimulated
with PMA/ionomycin (Sigma-Aldrich; St. Louis, MO) for 4–
6 h before the detection of IL-2, IFN-γ, TNF-α, and TGF-β1.
For apoptosis analysis, cells were stained with Annexin V and
7-AAD from the PE Annexin V apoptosis detection kit (BD

TABLE 2 | Primer sequences used for RT-qPCR experiments in the paper.
Primer sequences

Supplier

Catalog number

Gapdh forward, GGATTTGGTCGTATTGGG

Thermo Fisher

N/A

Gapdh reverse, GGAAGATGGTGATGGGATT

Thermo Fisher

N/A

Gas5 forward, GGACCGGGAGATAGGAGTG

Thermo Fisher

N/A

Gas5 reverse, CACGGACTCCAGGTGATGAG

Thermo Fisher

N/A

Gas5-mutant forward, ACAGATCAAGGTGAAGTTGAAATGGTGGAGTC

Thermo Fisher

N/A

Gas5-mutant reverse, AATTCATTTGTGTGCCAATGGCTTGAGTT

Thermo Fisher

N/A

hsa-miR-21-5p

Fisher Scientific

477975_A26676

hsa-miR-191-5p

Fisher Scientific

477952_A26676

This table provides the primer sequences, the supplier information and catalog number of each primer used for RT-qPCR experiments in this study.
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which can amplify all known isoforms of GAS5, and measured
expression levels by real-time RT-PCR. As shown in Figure 1A,
GAS5 transcripts were significantly lower in CD4 T cells from
PLHIV compared with HS (n = 8 subjects).
In addition to targeting protein-coding genes, lncRNAs can
also target miRNAs to regulate cellular responses and tumor
progression. Bioinformatics analysis using the RNA22 program
revealed that GAS5 has sequences complementary to several
miRNAs, including miR-21. We were interested in miR-21
because its expression is dynamically upregulated and regulates
T cell responses during T cell activation and differentiation. To
determine whether GAS5 plays a role in T cell dysfunctions
via regulating miR-21 expression during HIV infection, we
measured miR-21 levels in CD4 T cells isolated from ARTcontrolled PLHIV and HS by RT-qPCR. As shown in Figure 1B,
miR-21 expression was significantly increased in CD4 T cells
derived from PLHIV compared with HS (n = 8). Since miR21 is aberrantly upregulated during T cell activation and
differentiation, these results are in line with the overall immune
activation driven by chronic inflammation in ART-controlled,
latent HIV infection. Next, we compared miR-21 and GAS5
expressions in T cells derived from the same subjects. As shown
in Figure 1C, the decline in GAS5 levels closely correlated
with miR-21 upregulation in CD4 T cells from the same HIV
patients and HS (n = 8 subjects). Also, the level of GAS5
positively correlated, whereas miR-21 negatively correlated, with
the CD4 T cell counts in the peripheral blood of ART-controlled
PLHIV (Figures 1D,E). Taken together, these results indicate
that GAS5 is downregulated, whereas miR-21 is upregulated in
CD4 T cells during HIV infection, and that their expressions
correlate with CD4 T cell counts in the peripheral blood of
ART-controlled PLHIV.

Biosciences; San Jose, CA). Active caspase-3 was detected using
a cleaved caspase-3 staining kit (FITC or Red) following the
manufacturer’s instructions (Abcam; Cambridge, MA). For cell
cycle progression, TCR-stimulated CD4 T cells from PLHIV and
HS were harvested at days 1, 3, and 5 and stained with Propidium
Iodide (PI) using PI flow cytometry kit (Abcam) following
the manufacturer’s protocol. Samples were acquired on a BD
AccuriTM C6 flow cytometer and analyzed using Flowjo software.

Western Blot
Western Blot was performed as described previously (33).
The primary antibodies used were rabbit PARP-1 Ab (clone
46D11; Cat #9532), rabbit phospho-histone H2A.X Ab (Ser139)
(clone 20E3; Cat #9718), rabbit phospho-S6 ribosomal protein
(Ser235/236) Ab (clone D57.2.2E; Cat #4858), rabbit phosphoAkt (Ser473) XP Ab (clone D9E; Cat #4060), mouse AGO2
Ab (clone 2E12-1C9; Cat #57113), and rabbit GAPDH XP
mAb (clone D16H11; Cat #5174) (all from Cell Signaling
Technology; Danvers, MA). After washing, the blots were
incubated with appropriate horseradish peroxide-conjugated
secondary antibodies (Cell Signaling), and protein bands were
developed with the Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare). The chemiluminescent
signal was detected and quantified by Chemi DocTM MP Imaging
System (Bio-Rad) and normalized to GAPDH.

Statistical Analysis
The data were analyzed using Prism 7 software and are presented
as mean ± SEM or median with interquartile range. Statistical
outliers were removed by the ROUT method (Q = 1%).
Based on whether the values passed the D’Agostino-Pearson
normality or Kolmogorov-Smirnov test, either paired Student’s
t-test or Wilcoxon matched-pairs signed-rank test was used for
the analysis involving knockdown/overexpression experiments.
Likewise, independent unpaired Student’s t-test with Welch’s
correction or Mann Whitney U-test for non-paired experiments.
Correlations were analyzed by either Pearson’s or Spearman’s
correlation, depending on the data normal distribution test. P <
0.05 and P < 0.001 were considered statistically significant and
very significant, respectively.

Differential Expression of GAS5 and
miR-21 Following TCR Stimulation of
CD4 T Cells From PLHIV and HS
Although ART controls viral replication, PLHIV still exhibit
low-grade inflammation and immune activation, driving T cell
exhaustion and senescence. We thus hypothesized that the
differential expression of GAS5 and miR-21 in CD4 T cells is
likely due to overall immune activation, as additional TCR
stimulation in vitro could drive aberrant RNA expressions
further, but the response of CD4 T cells from PLHIV may be
attenuated due to their exhausted and senescent status. To test
this hypothesis, we cultured CD4 T cells from PLHIV and agematched HS (n = 6) with or without Dynabeads-coated with
anti-CD3 and anti-CD28 antibodies for 1, 3, and 5 days and
measured GAS5 transcripts by RT-qPCR. As shown in Figure 1F,
TCR stimulation decreased GAS5 levels in CD4 T cells from HS
at day 1 (p = 0.0997), day 3 (p = 0.0005), and day 5 (p =
0.0756), but such a decrease was only statistically significant at
day 3 compared to the unstimulated cells. Similarly, GAS5 levels
in CD4 T cells from PLHIV were also significantly downregulated
following TCR stimulation at day 3 (p = 0.0023) and day 5 (p =
0.0006), but not at day 1 (p = 0.0756; Figure 1G). These results

RESULTS
Differential Regulation of GAS5 and miR-21
Expressions in CD4 T Cells Derived From
PLHIV and HS
While thousands of lncRNAs have been identified in human
cells, only a small number have been experimentally validated
and shown to be associated with human diseases, particularly
with infectious diseases. Among these lncRNAs, GAS5 has been
shown to simultaneously target multiple genes involved in cell
growth and apoptosis. As a first step to elucidate the role of
GAS5 in T cell regulation during HIV infection, we measured its
expression in CD4 T cells isolated from ART-controlled PLHIV
and age-matched HS. Because human GAS5 encodes several
splicing isoforms (GAS5a and GAS5b, in addition to 5 GAS5
EST sequences) (37), we synthesized a primer set within exon 12,
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FIGURE 1 | Differential expression of GAS5 and miR-21 in CD4 T cells after TCR stimulation. (A,B) Relative expression of GAS5 (n = 8) and miR-21 (n = 8) in CD4 T
cells isolated from HS and PLHIV was determined by RT-qPCR. (C) Correlation between GAS5 and miR-21 expressions in CD4 T cells isolated from HS or PLHIV was
determined by Pearson correlation analysis. (D,E) Correlation between CD4 T cell counts and relative GAS5 (n = 8) or miR-21 (n = 8) expressions in CD4 T cells from
PLHIV was determined by Pearson Correlation analysis. (F,G) Relative expression of GAS5 in CD4 T cells from HS and PLHIV in the absence or presence of TCR
stimulation for 1, 3, and 5 days (n = 6). (H,I) Relative expression of miR-21 in HS and PLHIV CD4 T cells with or without TCR stimulation for 1, 3, and 5 days (n = 6).
(J) Relative expression of miR-21 in TCR-stimulated CD4 T cells from HS and PLHIV in 1, 3, and 5 days (n = 6). (K) Kinetic changes in miR-21 expression in CD4 T
cells from both PLHIV and HS following TCR stimulation for 1, 3, and 5 days. (L) Relative expression of miR-146a in CD4 T cells from HS and PLHIV with or without
TCR stimulation for 24 h (n = 6). (M) Representative dot blot and relative expression of AGO2 (a major component of RISK complex) in CD4 T cells from HS and
PLHIV with or without TCR stimulation for 24 h, determined by Western blotting (n = 6).

5 stimulation resulted in a slightly higher miR21 expression in
HIV samples (1.13-fold increase, p = 0.4887; Figure 1J). Also,
the changes in miR-21 expressions in CD4 T cells from both
PLHIV and HS following TCR stimulation in vitro for 1, 3, and
5 days are shown in Figure 1K and clearly show that miR-21 was
upregulated in CD4 T cells from both PLHIV and HS after TCR
stimulation. However, the response of CD4 T cells from PLHIV
was attenuated compared to cells from HS, especially at the early
phase (day 1–3) of TCR stimulation. Since the day 0 (baseline)
data for GAS5 and miR-21 expressions without TCR stimulation
are shown in Figures 1A,B, we did not include this time point
when we set up the TCR stimulation for the kinetic experiments
due to limited availability of the cells, which we recognize as a
limitation for the analysis of these data (Figures 1F–K).
Previous studies have shown that miR-146a is upregulated in
TCR-stimulated T cells and in HIV-1-infected individuals (38).
Also, the expression of miR-146 was found to be correlated with
the expressions of T cell exhaustion and senescence markers,
such as PD-1, Tim-3, and LAG-3 (38). Our data in Figure 1L
show that the levels of miR-146a were increased in CD4 T
cells from HS (p = 0.0304), but not PLHIV (p = 0.5096),
following TCR stimulation for 24 h. Also, we found no significant

demonstrate that TCR stimulation reduces GAS5 expression in
CD4 T cells derived from both HS and PLHIV.
To determine the effects of T cell activation on miR-21
regulation, we also measured miR-21 levels in CD4 T cells
from the same group of PLHIV and age-matched HS (n = 6
subjects) after TCR stimulation for 1, 3, and 5 days. Following
stimulation with bead-conjugated anti-CD3 and anti-CD28
antibodies, HS CD4 T cells responded robustly and kinetically,
with an increasing miR-21 expression, particularly at day 1 (>5fold increase, p = 0.0002) and day 3 (>3-fold increase, p =
0.0246; Figure 1H). Although HIV CD4 T cells also exhibited
increases in miR-21 expression after TCR stimulation, the
differences between unstimulated and stimulated cells were not
significant (fold-increases between 1 and 2 overtime, all p >
0.05; Figure 1I). These results indicate that CD4 T cells from
PLHIV respond to TCR stimulation poorly compared to those
from HS. Notably, miR-21 levels were remarkably higher in
CD4 T cells from PLHIV than HS without TCR stimulation in
vitro (Figure 1B), and were significantly lower in TCR-stimulated
CD4 T cells from PLHIV after the values were normalized to
the unstimulated cells, especially at day 1 (6.85-fold decrease, p
= 0.0241) and day 3 (1.7-fold decrease, p = 0.0099). The day
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Notably, the percentages of CD4 T cells from HS and PLHIV in
various cell cycle phases were comparable after TCR stimulation
for 1 day. We found a significant higher percentage of CD4 T
cells from HS were going through cell cycle phases compared
to those from PLHIV following TCR stimulation for 3–5 days,
particularly at day 3. These data indicate that TCR stimulation
induces cellular proliferation and division, but as the expression
GAS5 and miR-21 is altered in response to TCR stimulation,
CD4 T cells from PLHIV behave differently from HS; in that HSCD4 T cells respond relatively stronger and ultimately progress
to T cell exhaustion and senescence with persistent stimulation.
Attempts have been made to restore dampened T cell
functions in PLHIV via manipulating some of the dysregulated
signaling pathways. For instance, blockade of the inhibitory PD1/PD-L1 pathway enhanced viral-specific CD4 T cell response
along with a decreased viral replication (39, 40). In addition,
administration of IL-2 led to CD4 T cell expansion, and such
expansion was coupled with a decreased turnover and improved
survival of naive and central memory CD4 T cells, leading
to recovery of T cell function and immune response (41,
42). Here, we examined whether PD-1 blockade with IL2 signaling can impact the GAS5/miR-21 axis during TCR
stimulation by determining the levels of GAS5 and miR-21
in TCR-stimulated HIV-CD4 T cells in the presence of PD1 inhibitor (Nivolumab) and IL-2. As shown in Figure 2B,
anti-PD1 and IL-2 treatment could not restore the aberrant
GAS5/miR-21 expressions following TCR stimulation in CD4 T
cells from PLHIV.

differences in miR146 levels in CD4 T cells derived from PLHIV
and HS, in both unstimulated (P = 0.9776) and TCR-stimulated
(P = 0.7600) conditions (Figure 1L).
Argonaute 2 (AGO2) is the catalytic component of RISC
that recognizes and cleaves mRNA of complementary sequences.
From a duplex, one strand is preferentially loaded into AGO2
to generate a functional miRNA-induced silencing complex
(miRISC). We asked whether levels of AGO2 are affected during
TCR stimulation. To address it, we measured AGO2 in CD4 T
cells from HS and PHLIV with and without TCR stimulation for
24 hours. Although AGO2 expression was increased after TCR
stimulation in CD4 T cells from both HS and PHLIV sequence,
there were no significant differences in AGO2 levels, between the
two groups, in both unstimulated and stimulated (Figure 1M).
These data indicate that AGO2 expression levels are significantly
increased, with no differences between HS and HIV suggesting
that TCR stimulation may affect widely miRISC activity.

Effects of IL-2 and Anti-PD1 Treatment on
the GAS5-miR-21-Axis
To further define the effect of GAS5-miR-21 on T cell activities,
we measured cell cycle progression by PI staining in CD4 T cells
from HS and PLHIV, following TCR stimulation for 1, 3, and
5 days. As shown in Figure 2A (representative histogram for
numbers of CD4 T cells in G0/1, S, and G2/M phases at day 3
and summary data at day 1, 3, and 5), there were significant
differences in the percentages of CD4 T cells present in S and
G2/M phases of cell cycle with and without TCR stimulation.

FIGURE 2 | Cell cycle progression, AGO2 expression, and effect of anti-PD1/IL-2 in TCR-stimulated CD4 T cells on GAS5-miR-21 axis. (A) Cell cycle progression in
CD4 T cells from HS and PLHIV following TCR stimulation at day 1, 3, and 5 measured by PI flow cytometric analysis (n = 4). Representative histogram of cell cycle
phases of CD4 T cells from HS and PLHIV with and without TCR stimulation at day 3 are shown above and summary data at day 1, 3, 5 are shown below. (B) Relative
expression of GAS5 and miR-21 in CD4 T cells from HS and PLHIV following anti-PD1 and IL-2 treatments for 24 h, determined by RT-qPCR (n = 3). n.s, P > 0.05; *P
≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
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PLHIV on ART Exhibit T Cell Dysregulation
and Apoptosis due to Aberrant DDR

upregulated after TCR stimulation compared to CD4 T cells
from HS.
We have recently reported that chronic inflammation in
ART-controlled PLHIV induces telomeric DNA damage and cell
apoptosis. Here, we found that phosphorylation of the H2A
histone family member γH2AX (a marker of DNA damage)
was significantly upregulated by TCR stimulation in CD4 T cells
derived from both PLHIV and HS, and was further increased
in T cells from PLHIV, with or without TCR stimulation
(Figure 3D). Correspondingly, PLHIV had a high level of
CD4 T cell apoptosis, as evidenced by the significant increase in
cleaved caspase-3 and Av/7AAD levels, perhaps due to reduced
levels of Bcl-2 expression (an anti-apoptotic molecule), in
CD4 T cells under both unstimulated and stimulated conditions
compared to HS (Figure 3E). The DNA damage-mediated
cell apoptosis was confirmed by western blot, which showed
increases in the levels of cleaved PARP-1, pAKT, and γH2AX
in CD4 T cells from PLHIV compared to HS (Figure 3F).
These results suggest that CD4 T cells from PLHIV exhibit a
phenotype of over-activation, exhaustion, DNA damage, and
cell apoptosis.

To determine the possible effects of GAS5/miR-21 on the
cellular response during latent HIV infection, we examined
the expressions of known protein markers for T cell activation,
exhaustion, DNA damage, cellular functions, and apoptosis
using flow cytometry and western blotting. As shown in
Figure 3A, the frequencies of CD69 (an early activation
marker) positive cells were significantly increased upon
TCR stimulation of CD4 T cells from both PLHIV and HS;
however, PLHIV exhibited significantly increased T cell
activation at baseline prior to stimulation. Correspondingly,
phosphorylation of AKT (pAKT) was upregulated in CD4 T
cells from PLHIV after TCR stimulation. Because CD4 T
cells are persistently activated during HIV infection, they
expressed higher levels of the activation and exhaustion
marker programmed death-1 (PD-1) before and after TCR
stimulation compared to CD4 T cells from HS (Figure 3B).
Likewise, CD4 T cells from PLHIV showed relatively lower
levels of the survival cytokine interleukine-2 (IL-2) (Figure 3C),
whereas levels of the pro-inflammatory cytokine TGF-β1 were

FIGURE 3 | PLHIV on ART exhibit CD4 T cell dysregulation and apoptosis due to aberrant DDR. T cell activation, exhaustion, cytokine production, apoptosis, and
DNA damage marker expressions in TCR-stimulated or non-stimulated CD4 T cells isolated from HS or PLHIV were determined by Flow Cytometry and Western Blot.
(A) Frequency of CD69+ (n = 11) and MFI of pAKT+ cells (n = 11). (B) Representative dot plots and summary data of PD-1+ cells (n = 12). (C) Representative dot
plots and summary data of IL-2 expression (n = 12), expression of TGFβ1 (n = 8). (D) Representative histogram and summary MFI of γH2AX in CD4 T cells from HS (n
= 18) and PLHIV (n = 21). (E) Expression of active caspase-3 (n = 10), representative dot plots and summary data of Av+ 7AAD+ CD4 T cells from HS (n = 21) and
PLHIV (n = 25), expression of BCL-2 in CD4 T cells from HS and PLHIV (n = 8). (F) Representative imaging and summary data of immunoblotting for PARP-1, pAKT,
and γH2AX, normalized by GAPDH.
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miR-21 Controls CD4 T Cell Response and
Apoptosis via Regulating the TCR
Signaling Pathways in PLHIV

of miR-21 in CD4 T cells overexpressing GAS5. As shown in
Figure 5A, the level of miR-21 was downregulated in a dosedependent manner, depending on the amount of the lentivirus
(0, 1.35 × 106 TU/mL, and 2.70 × 106 TU/mL) to overexpress
GAS5, indicating that miR-21 level is regulated by GAS5 in
TCR-activated PLHIV CD4 T cells. These results demonstrate
that GAS5 negatively regulates miR-21 in TCR-activated PLHIV
CD4 T cells and provide a further evidence of an endogenous
competitive RNA regulatory network.

To examine whether and how miR-21 controls T cell response
during HIV infection, we transfected CD4 T cells with lentiviral
shRNA against miR-21, and assessed the markers for T cell
activation, exhaustion, DNA damage, and cellular apoptosis
by flow cytometry and western blotting. Figure 4A shows
knockdown of miR-21 as determined by a slight decrease in its
levels in CD4 T cells transfected with anti-miR21 compared to the
control vector. Notably, knockdown of miR-21 did not change
the expression of GAS5, indicating that GAS5 expression is not
regulated by miR-21. As shown in Figure 4B, the frequencies of
pAKT+ , pMAPK+ , PD-1+ , and Tim-3+ cells were significantly
reduced after miR-21 knockdown. Additionally, IL-2 and IFNγ expressions were increased, whereas the number of TGF-β1
expressing CD4 T cells from PLHIV was significantly decreased
(Figure 4C), after miR-21 knockdown.
It has been reported that T cell factor-1 (TCF1) critically
regulates T cell activation and differentiation through activation
of the canonical Wnt signaling pathway during TCR stimulation
(43). We thus examined TCF1 expression in PLHIV CD4 T
cells following miR-21 knockdown. As shown in Figure 4C,
the percentage (%) of TCF1+ cells was significantly decreased
in PLHIV CD4 T cells transfected with anti-miR-21 siRNA
compared to the control. Moreover, the frequencies of
Av+ /7AAD+ cells and the MFI of cleaved caspase-3 (Figure 4D)
and the MFI of DNA damage marker γH2AX (Figure 4E) were
significantly decreased, in PLHIV CD4 T cells with miR-21
knockdown. To further confirm the changes in the expression of
these markers, we measured their levels by Western blotting. As
shown in Figure 4F (representative blots and summary data), the
levels of cleaved PARP-1, pS6, and γ-H2AX were downregulated
after miR-21 knockdown. These results indicate that disrupting
miR-21-mediated signaling can rescue PLHIV CD4 T cells from
over-activation, exhaustion, cytokine inhibition, DNA damage,
and cell apoptosis.

GAS5 Controls CD4 T Cell Responses and
Apoptosis During HIV Infection by
Regulating Pathways Beyond
miR-21-Mediated Signaling
GAS5 not only regulates miR-21 expression, but also other
miRNAs involved in cellular differentiation and proliferation (44,
45). To investigate the regulatory effect of GAS5 on CD4 T cells
during HIV infection, independently from miR-21-mediated
signaling, we generated a GAS5 mutant where amino acids
at exon 4 of GAS5 transcript were altered (GAS5-mutant), as
depicted in Figure 5B. This mutation abolishes the binding site
of miR-21 on GAS5 and thus restricts the interaction between
GAS5 and miR-21. Notably, transfection with GAS5-mutant did
not significantly alter miR-21 levels compared to control vector,
whereas transfection with GAS5-WT significantly decreased
miR-21 level (p = 0.0293), suggesting that overexpression of
GAS5-mutant with no binding affinity for miR-21 does not
affect miR-21 expression. We next determined the effect of
overexpressing GAS5-mutant on T cell activation and responses.
As shown in Figure 5C, the expression of early T cell activation
marker CD69, was significantly (p = 0.0025) downregulated
in CD4 T cells transfected with GAS5-WT compared to the
control vector transfection. However, the CD69 expression
was partially restored in CD4 T cells overexpressing GAS5mutant compared to the GAS5-WT, and this change was not
statistically significant compared to the control. In addition,
we observed a significantly lower apoptosis rate in CD4 cells
overexpressing GAS5-WT, but not GAS5-mutant compared, to
the control vector (Figure 5D). Nevertheless, the frequencies
of T cells expressing PD-1 and pAKT were significantly
downregulated in CD4 T cells overexpressing GAS5-WT and
GAS5-mutant compared to the control vector (Figure 5E).
These results suggest that while GAS5 regulates HIV-CD4 T
cell early activation and apoptosis through miR-21-mediated
signaling, other signaling pathways may also be involved in the
regulation of T cell activation and exhaustion pathways during
HIV infection.

GAS5 Negatively Regulates miR-21
Expression in TCR-Activated CD4 T Cells
From PLHIV and HS
How GAS5 and miR-21 are differentially regulated by TCR
stimulation is poorly understood. As stress-inducible genes,
GAS5 and miR-21 are induced in response to cellular stress
conditions, such as serum starvation or TCR stimulation.
Although previous studies have shown that GAS5 and miR-21
regulate each other’s expression in a mutually exclusive way,
our results in Figure 4A showed that GAS5 expression was
not significantly increased after miR-21 knockdown in PLHIV
CD4 T cells. In addition, we determined the effect of GAS5
on miR21 expression by overexpressing GAS5 in TCR-activated
PLHIV CD4 T cells using the lentivirus expression system,
followed by examining GAS5 and miR21 expression. The data
in Figure 5A confirmed a significant increase in GAS5 levels in
TCR-stimulated HIV-CD4 T cells (2 days) transfected with GAS5
(p = 0.0034) for additional 3 days. We next determined the levels
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GAS5 Controls CD4 T Cell Response and
Apoptosis by Regulating miR-21-Mediated
Signaling During HIV Infection
Having demonstrated a negative regulatory effect of GAS5
on miR-21 expression, we next examined the functional role
of GAS5 in CD4 T cell regulation. We investigated whether
overexpression of GAS5 has any effect on miR-21-mediated
functional changes in CD4 T cells from PLHIV. GAS5 was
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FIGURE 4 | MiR-21 controls CD4 T cell response and apoptosis via regulating the TCR signaling pathways in PLHIV. T cell activation, exhaustion, cytokine production,
apoptosis, and DNA damage marker expressions after miR-21 knockdown in CD4 T cells from PLHIV were determined by Flow Cytometry and Western Blot. (A)
Relative expression of miR-21 and GAS5 following miR-21 knockdown in CD4 T cells from PLHIV determined by RT-qPCR (n = 5). (B) Frequencies of pMAPK (n = 9),
pAKT (n = 9), PD-1 (n = 11), and Tim-3 (n = 8). (C) Representative dot plot and summary data of IL-2 (n = 16), IFN-γ (n = 16), TGFβ1 (n = 8), and TCF1 (n = 7)
expressions. (D) Representative dot plot and summary data of Av+ 7AAD+ CD4 T cells (n = 13), expression of active caspase-3 (n = 10). (E) Representative
histogram and summary data of γH2AX expression (n = 12). (F) Representative western blots and summary data of cleaved PARP-1 (n = 8), pS6 (n = 6), and γH2AX
(n = 6) expressions, normalized to GAPDH.

FIGURE 5 | GAS5 controls CD4 T cell response and apoptosis beyond miR-21-mediated signaling pathways. (A) Relative expressions of GAS5 (n = 5) and miR-21 (n
= 4) in CD4 T cells from PLHIV, following overexpression of GAS5, determined by RT-qPCR. (B) Left panel, sequences of GAS5-mutant and GAS5-WT constructs,
and the corresponding miR-21 binding site. Right panel, relative miR-21 expression in CD4 T cells from PLHIV transfected with control, GAS5-WT, or GAS5-mutant
constructs (n = 6). (C–E) Expression of T cell activation, apoptosis, and exhaustion markers in CD4 T cells from PLHIV transfected with control, GAS5-WT, or
GAS5-mutant construct, determined by flow cytometry (n = 10).
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DISCUSSION

overexpressed using the lentiviral expression system, and the
markers for functional T cells were assessed by flow cytometry
and western blotting. As shown in Figure 6A, the frequencies
of pAKT+ and pMAPK+ cells were significantly decreased;
PLHIV CD4 T cell exhaustion was reduced, as demonstrated by
the downregulation of PD-1+ and Tim-3+ cell frequencies in
GAS5-overexpressing CD4 T cells (Figure 6B). Additionally, IL2 and IFN-γ producing CD4 T cells were increased (Figure 6C),
whereas pro-inflammatory TNF-α producing cells were
decreased due to GAS5 overexpression (Figure 6D). Moreover,
the level of γH2AX was reduced (Figure 6E), and the cell
apoptosis markers Av/7AAD and cleaved caspase-3 were
significantly decreased in GAS5 overexpressing CD4 T cells
compared to the control vector expression (Figure 6F). To
further confirm the changes in the expressions of these
markers, we determined their levels by western blotting. As
shown in Figure 6G (representative blots and summary data),
protein levels of cleaved PARP-1, pS6, and γH2AX, were
downregulated in GAS5-overexpressing cells compared to the
control vector. These results suggest that increasing GAS5
levels in PLHIV CD4 T cells can negatively regulate miR-21
expression, which in turn improves TCR activation, T cell
exhaustion, cytokine production, and reduces DNA damage
and cell apoptosis.

T cells play an essential role in the control of viral infections.
However, T cells in PLHIV–despite successful control of viral
replication by ART–are aberrantly dysregulated and exhibit an
immune aging phenotype, characterized by CD4 T cell overactivation, exhaustion, senescence, accumulated DNA damage,
more apoptosis, and impaired cellular functions. While the
causes for this immune aging phenotype have been extensively
investigated, the molecular mechanisms underlying these cellular
alterations remain incompletely understood. In this study, we
demonstrated that GAS5 and miR21 are differentially expressed
in CD4 T cells derived from ART-controlled PLHIV and that
GAS5 controls miR21 expression to regulate signaling molecules
involved in DNA damage and cellular responses following T cell
receptor (TCR) stimulation. Based on these new findings and our
previous studies–showing deficiencies in topoisomerase I/IIα
(Top1/2α), ataxia-telangiectasia mutated, human telomerase
reverse transcriptase (hTERT), and telomeric repeat-binding
factor 2 (TRF2) that can cause telomeric DNA damage–we
propose a model (depicted in Figure 7) illustrating how the
GAS5-miR21 axis controls the function and fate of CD4 T cells in
PLHIV. Despite the differential expressions of GAS5 and miR-21,
the mechanism of miR21-mediated dysregulation of CD4 T cell

FIGURE 6 | GAS5 controls CD4 T cell response and apoptosis via regulating miR-21-mediated signaling in PLHIV. (A,B) Frequencies of pAKT (n = 11), pMAPK (n =
7), PD-1 (n = 10), and Tim-3 (n = 11) in control vector or GAS5-transducted CD4 T cells from PLHIV, determined by flow cytometry. (C,D) Representative dot plot and
summary data of IL-2 expression (n = 10), IFN-γ (n = 12), and TNF-α (n = 5), measured by flow cytometry. (E) Representative histogram and summary data of γH2AX
expression (n = 9). (F) Representative dot plot and summary data of Av+ 7AAD+ CD4 T cells (n = 10) and active caspase-3 (n = 11). (G) Representative western blot
imaging and summary data of cleaved PARP-1 (n = 6), pS6 (n = 4), and γH2AX (n = 6) expressions, normalized to GAPDH.
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FIGURE 7 | A model depicting how the GAS5-miR-21 axis controls the function and fate of CD4 T cells in PLHIV. Two crucial non-coding RNAs, GAS5 and miR-21
are differentially expressed in CD4 T cells in PLHIV. The decline in GAS5 and increase in miR-21 expressions, along with the deficiencies in crucial enzymatic proteins
involved in DNA damage and repair machineries, can cause significant increases in CD4 T cell activation, senescence, apoptosis, DNA damages, and dysregulation of
cytokine productions established during latent HIV infection. Importantly, interrupting this GAS5-miR-21 axis may restore T cell homeostasis and competency and
resolve premature T cell aging or immune senescence. Notably, GAS5 effects on T cell exhaustion during HIV infection may be mediated by mechanism(s) beyond
GAS5-miR21 mediated signaling. Bottom: Deficiencies in Top1/2a, ATM, hTERT, and TRF2 that can cause telomeric DNA damage (30–34, 36) are known to
contribute to dysfunctional CD4 T cells in HIV patients.

functions in PLHIV remain unknown. Nevertheless, our data
clearly show that the GAS5-miR21 axis can control multiple
signaling pathways involved in cell activation, senescence, and
apoptosis in PLHIV CD4 T cells. Notably, the decline in GAS5
and the increase in miR21 are associated with the frequencies of
CD4 T cells in the peripheral blood of PLHIV. Importantly,
GAS5 overexpression or miR21 silencing significantly
restored the aberrantly dysregulated T cell activation, DNA
damage, apoptosis, and functions of CD4 T cells derived from
PLHIV. Additionally, disrupting miR21 binding site in GAS5
transcripts partially restored the GAS5-mediated regulation of
CD4 T cell activation and apoptosis but not cell exhaustion,
indicating that additional signaling pathways are involved in
T cell exhaustion.
Previous studies in cancer have suggested that GAS5 puts
a “brake” on cell proliferation, thereby acting as a potential
tumor suppressor in various cancers (46). Also, overexpression of
GAS5 has been shown to increase apoptosis and reduce cell cycle
progression in T cell lines and PBMCs (47). In contrast, low levels
of GAS5 are often associated with cell proliferation and cancer
metastasis (48). These findings in cancer cells seem to contradict
our data showing that decreasing GAS5 in the CD4 T cells of
PLHIV resulted in a dampened response in these prematurely
aged cells while overexpressing GAS5 restored their dysregulated
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functions. As a multifunctional lncRNA, GAS5 plays crucial
roles in many biological processes, including transcriptional
regulation, by acting as a decoy or through promoting histone
modifications or competing with endogenous RNA (ceRNA)
to regulate various signaling pathways and biological functions
(49). Thus, GAS5 expression and functions can be species-,
cell-, or disease-specific. In addition, miR-21 is considered a cell
activation marker and an oncogene, where its upregulation can
cause an overgrowth of many cancers (50). In contrast, it has
been shown to be a negative regulator of T cell activation. High
expression of miR-21 in T lymphocytes can reduce activation
marker (CD69, OX40, CD25, and CD127) and cytokine (IL-2,
IFN-γ) gene expressions, and hence, induce T cell over-activation
and dysfunction (51). Furthermore, it has been reported that
upregulation of miR-21 level in the elderly drives proliferation
of naïve T cells to a terminal phenotype instead of a longlived memory phenotype, thus attenuating T cell responses;
this strongly supports our findings, including TCF1 declines
upon miR-21 silencing in this study. Previous studies have
shown that miR-21 targets several pathways involved in cellular
proliferation. The tumor-suppressor pathway–phosphatase and
tension homolog (PTEN)/phosphoinositide 3-kinases (PI3K)–
is a well-known target of miR-21 (52). Also, miR-21 has been
shown to target the programmed cell death 4 (PDCD4)/p21
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and social-related stresses (56–63), all of which may contribute to
the failure to restore CD4 T cell homeostasis and/or functionality.
These factors can lead to persistent, low-grade inflammation,
causing T cell over-activation, exhaustion, senescence, apoptosis,
and decreased proliferative potential, as our results suggest.
Importantly, such inflammation-driven DNA damage promotes
an inflammaging phenotype and exposes the immune system
to unique challenges that could lead to CD4 T cell exhaustion,
senescence, apoptosis, and homeostasis–a major driver of the
increased incidences of infections, cancers, cardiovascular, and
neurodegenerative diseases, similar to that observed in the
elderly. Therefore, this premature immune aging process puts
PLHIV at greater risk of morbidity and mortality.
It should be pointed out that, while the decrease in GAS5
and increase in miR-21 can explain both DNA damage and cell
apoptosis, their presence can also result in both overwhelming
cell death in acute infection and immune tolerance or immune
suppression in chronic infection. Nevertheless, our findings
identify, for the first time, the role of the GAS5-miR-21 axis
in CD4 T cell dysregulation in PLHIV and shed light on the
molecular aspects of immunomodulation during human viral
infections. Given the broad regulatory effects of both GAS5
and miR-21, the decline in GAS5 and increase in miR-21 may
impair diverse cellular functions during chronic HIV infection.
Thus, interrupting this GAS5-miR21 axis may restore CD4 T cell
homeostasis and competency during latent HIV infection and
prevent premature CD4 T cell aging or immune senescence. This
study reveals a novel molecular mechanism underlying CD4 T
cell aging and provides a new strategy to develop innovative
approaches to correct the aberrant immunopathology, to avoid
the untoward consequences of immune senescence and to
improve immunotherapy as well as vaccine responses against
human viral diseases.

and Sprouty RTK Signaling Antagonist 1 (SPRY1)/Rapidly
Accelerated Fibrosarcoma (RAF) signaling pathways (53, 54).
Also, we and others have shown that chronic viral infectioninduced inflammaging phenotypes result from deficiencies in
Top 1/2α, ATM, hTERT, and TRF2, which correlate closely with
the observed, aberrant CD4 T cell apoptosis and depletion. Here,
we further demonstrate that a decrease in GAS5 level promotes
the upregulation of miR-21 expression and that the GAS5-miR21 axis may represent a key signaling pathway in controlling
persistent activation, exhaustion, senescence, DNA damage, cell
apoptosis, and cytokine dysregulation in CD4 T cells derived
from PLHIV. Our data showed that GAS5 regulates CD4 T
cell responses, not only through miR-21-mediated signaling
but also via other undetermined pathways. In support of this
notion, we showed that manipulating GAS5/miR-21 expressions
or interactions during TCR activation can partially reverse CD4 T
cell dysfunctions and apoptosis. These findings provide a novel
strategy to improve immunotherapies and vaccine responses in
the setting of human viral infection.
PLHIV on ART represent the major HIV-infected population
in the era of ART. In this clinical setting, how the differential
expression of GAS5 and miR-21 ultimately control CD4 T
cell functions remains unknown. Given ART control of HIV
replication leads to a very small proportion (one in a million) of
PBMCs harboring HIV provirus (55), it is unlikely that HIV itself
per se can cause GAS5 downregulation and miR-21 upregulation
to compromise CD4 T cell functions. While data regarding GAS5
and miR-21 expression at day 0 (baseline level) are included
in Figures 1A,B, we did not include this time point in the
kinetic experiments due to limited cell volumes. However, our
TCR kinetic stimulation results (Figures 1F–K) clearly indicate
that GAS5 and miR-21 expressions are significantly regulated
by T cell activation status. Notably, higher amounts of miR21 and miR-146, along with Ago2, were detected in CD4 T
cells from HIV and HS under TCR stimulation conditions, but
with no significant differences between HIV and HS, indicating
that the altered function of miR-21 in CD4 T cells is driven by
GAS5 rather than Ago2. Since miRNAs form a duplex–with one
strand preferentially loaded into AGO2 to generate a functional
miRNA-induced silencing complex (miRISC)–it is likely that
more miRNAs are loaded onto the Ago2-miRISC in CD4 T
cells under TCR activation. Indeed, we and others have shown
that ART-controlled PLHIV with no detectable viral replication
can still exhibit an immune aging phenotype. We thus believe
that the observed changes in GAS5 and miR-21 expression and
dysregulations of CD4T cell functions in these virus-controlled
PLHIV are likely induced by either immunologic scarring during
early active viral infection or, perhaps more likely, by lowgrade inflammation and persistent T cell activation during latent
viral infection, or both. Our interpretation of the cumulative
data would include the notion that CD4 T cells in PLHIV
on ART exhibit an immune aging phenotype induced by a
myriad of viral/host factors, including HIV reservoirs, that
may secrete undetectable viral components, pro-inflammatory
mediators, increased ROS levels, increased gut permeability and
gut microbiota, coinfection with other pathogens (such as HBV,
HCV, EBV, and CMV), ART regimens, associated malignancies,
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